Sharda Cropchem Peer Comparison

NSE: SHARDACROP | BSE: 538666

₹742.05

₹0.30 (0.04%)

As on 07-Oct-2026IST

Market cap

₹6,700 Cr

Revenue (TTM)

₹5,357 Cr

P/E Ratio

10.7

P/B Ratio

2.1

Div. Yield

2 %

Edit

	Sharda Cropchem	Sumitomo Chemical	Bayer Cropscience	Dhanuka Agritech	Rallis India
Market cap (₹ Cr)	6,700	21,104	15,688	3,977	3,887
Revenue (₹ Cr)	5,357	3,245	5,595	1,953	2,962
Net Profit (₹ Cr)	626.21	579.39	732.10	268.04	214.00
Net Margin (%)	11.46	17.04	12.71	13.42	7.12
RoE (%)	21.55	17.35	24.05	16.62	13.45
Price to Earnings	10.70	36.42	21.43	14.84	18.17
Price-To-Book	2.08	5.86	4.77	2.41	1.79

Income Statement (₹ Cr)

	Sharda Cropchem	Sumitomo Chemical	Bayer Cropscience	Dhanuka Agritech	Rallis India
Operating Revenue	5,356.54	3,244.88	5,595.40	1,953.43	2,962.00
Total Income	5,464.12	3,400.10	5,760.60	1,997.26	3,005.00
Total Expenditure	4,309.62	2,559.91	4,702.50	1,578.13	2,566.00
EBITDA	1,046.92	684.97	892.90	375.30	396.00
Depreciation	346.70	67.63	116.90	63.32	118.00
EBIT	700.22	617.34	776.00	311.98	278.00
Interest	3.01	8.16	19.40	3.22	8.00
Other Income	107.59	155.22	165.20	43.83	43.00
Exceptional Items	0.00	10.82	0.00	0.00	-24.00
Profit before Tax	804.80	775.21	921.80	352.59	289.00
Provision for Tax	178.58	195.82	189.70	84.55	75.00
Profit after Tax	626.21	579.39	732.10	268.04	214.00

	Sharda Cropchem	Sumitomo Chemical	Bayer Cropscience	Dhanuka Agritech	Rallis India
Shareholder's Funds	3,136.49	3,389.67	2,965.70	1,681.88	2,043.00
Minority Interest	-0.09	0.06	0.00	0.00	0.00
Non-Current Liabilities	257.07	110.60	166.20	49.56	78.00
Current Liabilities	2,386.20	969.81	2,567.50	370.59	1,224.00
Total Liabilities	5,890.22	4,473.76	9,033.00	2,102.02	4,248.66

	Sharda Cropchem	Sumitomo Chemical	Bayer Cropscience	Dhanuka Agritech	Rallis India
Non-Current Assets	1,259.56	941.45	598.20	573.43	844.00
Current Assets	4,438.10	3,340.15	4,918.30	1,517.34	2,309.00
Total Assets	5,890.22	4,473.76	9,033.00	2,102.02	4,248.66
Total Debt*	0.00	1.50	0.00	0.90	6.90
Net Current Assets	2,051.90	2,370.34	2,350.80	1,146.75	1,085.00
Contingent Liabilities	17.55	60.07	765.30	187.63	274.02

	Sharda Cropchem	Sumitomo Chemical	Bayer Cropscience	Dhanuka Agritech	Rallis India
Cash From Operating Activities	655.69	445.51	1,078.50	196.20	172.11
Cash Flow from Investing Activities	-513.07	-331.95	72.50	-118.05	-94.88
Cash from Financing Activities	-118.28	-82.88	-623.80	-59.79	-66.16
Net Cash Inflow / Outflow	24.34	30.68	527.20	18.36	11.07

	Sharda Cropchem	Sumitomo Chemical	Bayer Cropscience	Dhanuka Agritech	Rallis India
ROCE (%)	31.10	23.39	30.08	24.44	13.23
ROE (%)	21.55	17.35	24.05	16.62	13.45
ROA (%)	11.92	13.73	13.38	13.74	6.77
EBIT Margin (%)	13.07	19.02	13.87	15.97	9.39
Net Margin (%)	11.46	17.04	12.71	13.42	7.12
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Sharda Cropchem	Sumitomo Chemical	Bayer Cropscience	Dhanuka Agritech	Rallis India
Revenue Growth (%)	18.52	-3.61	-2.80	-5.63	4.41
EBIT Growth (%)	68.35	-0.95	22.55	-15.57	25.23
Net Profit Growth (%)	49.11	3.86	23.56	-11.71	24.42
EPS Growth (%)	49.11	2.55	23.56	-11.57	60.86
Book Value Growth (%)	25.43	16.84	4.05	19.90	7.28

	Sharda Cropchem	Sumitomo Chemical	Bayer Cropscience	Dhanuka Agritech	Rallis India
Price / Earnings	10.70	36.94	21.43	14.98	14.12
Price / Book Value	2.08	5.86	4.77	2.41	1.79
Dividend Yield (%)	2.02	0.31	4.30	0.22	1.50
EV/EBITDA	5.84	29.34	15.91	9.81	8.45
Market Cap (₹ Cr)	7,846.59	18,203.86	20,885.70	4,048.67	4,235.19

	Sharda Cropchem	Sumitomo Chemical	Bayer Cropscience	Dhanuka Agritech	Rallis India
Debt to Equity	0.00	0.00	0.00	0.00	0.00
Short term debt to equity ratio	--	--	--	0.00	0.00
Current Ratio	1.86	3.44	1.92	4.09	1.89
Quick Ratio	1.39	2.65	1.08	2.70	1.10
Interest Coverage	268.73	95.97	48.52	110.47	37.13

	Sharda Cropchem	Sumitomo Chemical	Bayer Cropscience	Dhanuka Agritech	Rallis India
Debtors to sales (%)	44.60	22.67	19.94	22.56	20.80
Asset Turnover	1.02	0.77	1.02	1.00	0.94
Receivable days	142.20	77.14	56.33	75.54	57.86
Inventory Days	68.45	74.64	122.54	76.86	85.52
Payable days	151.79	95.86	131.57	55.32	126.20
Cash Conversion Cycle	58.86	55.92	47.30	97.08	17.18

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.